Literature DB >> 24829360

Emergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis.

Ke Zhuang1, Ana Rachel Leda1, Lily Tsai1, Heather Knight2, Carole Harbison2, Agegnehu Gettie1, James Blanchard3, Susan Westmoreland2, Cecilia Cheng-Mayer4.   

Abstract

UNLABELLED: Human immunodeficiency virus type 1 (HIV-1) infection in the central nervous system (CNS) is characterized by replication in macrophages or brain microglia that express low levels of the CD4 receptor and is the cause of HIV-associated dementia and related cognitive and motor disorders that affect 20 to 30% of treatment-naive patients with AIDS. Independent viral envelope evolution in the brain has been reported, with the need for robust replication in resident CD4(low) cells, as well as CD4-negative cells, such as astrocytes, proposed as a major selective pressure. We previously reported giant-cell encephalitis in subtype B and C R5 simian-human immunodeficiency virus (SHIV)-infected macaques (SHIV-induced encephalitis [SHIVE]) that experienced very high chronic viral loads and progressed rapidly to AIDS, with varying degrees of macrophage or microglia infection and activation of these immune cells, as well as astrocytes, in the CNS. In this study, we characterized envelopes (Env) amplified from the brains of subtype B and C R5 SHIVE macaques. We obtained data in support of an association between severe neuropathological changes, robust macrophage and microglia infection, and evolution to CD4 independence. Moreover, the degree of Env CD4 independence appeared to correlate with the extent of astrocyte infection in vivo. These findings further our knowledge of the CNS viral population phenotypes that are associated with the severity of HIV/SHIV-induced neurological injury and improve our understanding of the mechanism of HIV-1 cellular tropism and persistence in the brain. IMPORTANCE: Human immunodeficiency virus type 1 (HIV-1) infection of astrocytes in the brain has been suggested to be important in HIV persistence and neuropathogenesis but has not been definitively demonstrated in an animal model of HIV-induced encephalitis (HIVE). Here, we describe a new nonhuman primate (NHP) model of R5 simian-human immunodeficiency virus (SHIV)-induced encephalitis (SHIVE) with several classical HIVE features that include astrocyte infection. We further show an association between severe neuropathological changes, robust resident microglia infection, and evolution to CD4 independence of viruses in the central nervous system (CNS), with expansion to infection of truly CD4-negative cells in vivo. These findings support the use of the R5 SHIVE models to study the contribution of the HIV envelope and viral clades to neurovirulence and residual virus replication in the CNS, providing information that should guide efforts to eradicate HIV from the body.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829360      PMCID: PMC4135954          DOI: 10.1128/JVI.01237-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants.

Authors:  T K Smit; B Wang; T Ng; R Osborne; B Brew; N K Saksena
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

2.  Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.

Authors:  C C LaBranche; T L Hoffman; J Romano; B S Haggarty; T G Edwards; T J Matthews; R W Doms; J A Hoxie
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 3.  The end of AIDS: HIV infection as a chronic disease.

Authors:  Steven G Deeks; Sharon R Lewin; Diane V Havlir
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

4.  The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.

Authors:  N Bannert; D Schenten; S Craig; J Sodroski
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.

Authors:  Benjamin B Gelman; Joshua G Lisinicchia; Susan Morgello; Eliezer Masliah; Deborah Commins; Cristian L Achim; Howard S Fox; Dennis L Kolson; Igor Grant; Elyse Singer; Constantin T Yiannoutsos; Seth Sherman; Gary Gensler; David J Moore; Tiansheng Chen; Vicki M Soukup
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

6.  Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques.

Authors:  Carole Harbison; Ke Zhuang; Agegnehu Gettie; James Blanchard; Heather Knight; Peter Didier; Cecilia Cheng-Mayer; Susan Westmoreland
Journal:  J Neurovirol       Date:  2014-01-25       Impact factor: 2.643

Review 7.  Emerging roles of astrocytes in neural circuit development.

Authors:  Laura E Clarke; Ben A Barres
Journal:  Nat Rev Neurosci       Date:  2013-04-18       Impact factor: 34.870

8.  Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.

Authors:  Wuze Ren; Alexandra Mumbauer; Agegnehu Gettie; Michael S Seaman; Kasi Russell-Lodrigue; James Blanchard; Susan Westmoreland; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

9.  The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection.

Authors:  Lily Tsai; Ivan Tasovski; Ana Rachel Leda; Mario P S Chin; Cecilia Cheng-Mayer
Journal:  Retrovirology       Date:  2014-03-11       Impact factor: 4.602

10.  Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children.

Authors:  Christa Buckheit Sturdevant; Anna Dow; Cassandra B Jabara; Sarah B Joseph; Gretja Schnell; Nobutoki Takamune; Macpherson Mallewa; Robert S Heyderman; Annelies Van Rie; Ronald Swanstrom
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

View more
  10 in total

1.  SIV Infection Impairs the Central Nervous System in Chinese Rhesus Macaques.

Authors:  Hang Liu; Qian-Hao Xiao; Jin-Biao Liu; Jie-Liang Li; Li Zhou; Qiao-Yang Xian; Yong Wang; Jing Zhang; Xu Wang; Wen-Zhe Ho; Ke Zhuang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-06       Impact factor: 4.147

2.  Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4.

Authors:  Guan-Han Li; Caroline Anderson; Laura Jaeger; Thao Do; Eugene O Major; Avindra Nath
Journal:  AIDS       Date:  2015-04-24       Impact factor: 4.177

Review 3.  Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND).

Authors:  Zaina Zayyad; Serena Spudich
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 4.  HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest?

Authors:  Ashok Chauhan; Akshay Tikoo; Jankiben Patel; Arwa Mujahid Abdullah
Journal:  Neurosci Res       Date:  2014-09-08       Impact factor: 3.304

5.  Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice.

Authors:  Xilin Wu; Li Liu; Ka-Wai Cheung; Hui Wang; Xiaofan Lu; Allen Ka Loon Cheung; Wan Liu; Xiuyan Huang; Yanlei Li; Zhiwei W Chen; Samantha M Y Chen; Tong Zhang; Hao Wu; Zhiwei Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-02       Impact factor: 4.147

6.  Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology.

Authors:  Katharine J Bar; Ernesto Coronado; Tiffany Hensley-McBain; Megan A O'Connor; Jessica M Osborn; Charlene Miller; Toni M Gott; Solomon Wangari; Naoto Iwayama; Chul Y Ahrens; Jeremy Smedley; Cassie Moats; Rebecca M Lynch; Elias K Haddad; Nancy L Haigwood; Deborah H Fuller; George M Shaw; Nichole R Klatt; Jennifer A Manuzak
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

7.  Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.

Authors:  Hui Li; Shuyi Wang; Rui Kong; Wenge Ding; Fang-Hua Lee; Zahra Parker; Eunlim Kim; Gerald H Learn; Paul Hahn; Ben Policicchio; Egidio Brocca-Cofano; Claire Deleage; Xingpei Hao; Gwo-Yu Chuang; Jason Gorman; Matthew Gardner; Mark G Lewis; Theodora Hatziioannou; Sampa Santra; Cristian Apetrei; Ivona Pandrea; S Munir Alam; Hua-Xin Liao; Xiaoying Shen; Georgia D Tomaras; Michael Farzan; Elena Chertova; Brandon F Keele; Jacob D Estes; Jeffrey D Lifson; Robert W Doms; David C Montefiori; Barton F Haynes; Joseph G Sodroski; Peter D Kwong; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 12.779

8.  Productive HIV infection in astrocytes can be established via a nonclassical mechanism.

Authors:  Guan-Han Li; Dragan Maric; Eugene O Major; Avindra Nath
Journal:  AIDS       Date:  2020-06-01       Impact factor: 4.632

9.  Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N-Infected Rhesus Macaques.

Authors:  Manxue Jia; Hong Lu; Xiang-Peng Kong; Cecilia Cheng-Mayer; Xueling Wu
Journal:  Viruses       Date:  2018-05-16       Impact factor: 5.048

10.  Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions.

Authors:  Silvana Valdebenito; Shaily Malik; Ross Luu; Olivier Loudig; Megan Mitchell; George Okafo; Krishna Bhat; Brendan Prideaux; Eliseo A Eugenin
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.